Skip to Content
Merck
  • Myoglobinuric acute renal failure in a cardiac transplant patient taking lovastatin and cyclosporine.

Myoglobinuric acute renal failure in a cardiac transplant patient taking lovastatin and cyclosporine.

Journal of the American Society of Nephrology : JASN (1994-08-01)
D S Alejandro, J Petersen
ABSTRACT

Acute renal failure can occur in cardiac transplant patients for a variety of reasons. A case of a patient who developed acute renal failure secondarily to drug-induced rhabdomyolysis is reported. The literature regarding acute renal failure and lovastatin and other 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors is reviewed. The potential mechanisms of myoglobinuria and nephrotoxicity and the therapeutic implications are discussed.

MATERIALS
Product Number
Brand
Product Description

Lovastatin, European Pharmacopoeia (EP) Reference Standard
USP
Lovastatin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Mevinolin from Aspergillus sp., ≥98% (HPLC)
Supelco
Lovastatin, Pharmaceutical Secondary Standard; Certified Reference Material
Lovastatin for peak identification, European Pharmacopoeia (EP) Reference Standard